• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preclinical research models for endometrial cancer: development and selection of animal models.子宫内膜癌的临床前研究模型:动物模型的建立与选择
Front Oncol. 2025 Feb 5;15:1512616. doi: 10.3389/fonc.2025.1512616. eCollection 2025.
2
Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool.基因组验证子宫内膜癌患者来源异种移植模型作为一种临床前工具。
Int J Mol Sci. 2022 Jun 3;23(11):6266. doi: 10.3390/ijms23116266.
3
Murine Xenograft Models as Preclinical Tools in Endometrial Cancer Research.小鼠异种移植模型作为子宫内膜癌研究中的临床前工具
Cancers (Basel). 2024 Nov 28;16(23):3994. doi: 10.3390/cancers16233994.
4
Organoid development and applications in gynecological cancers: the new stage of tumor treatment.类器官在妇科癌症中的发展与应用:肿瘤治疗的新阶段。
J Nanobiotechnology. 2025 Jan 16;23(1):20. doi: 10.1186/s12951-024-03086-z.
5
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.在上消化道癌症中具有前景的临床前患者来源的类器官 (PDO) 和异种移植 (PDX) 模型:进展与挑战。
BMC Cancer. 2023 Dec 7;23(1):1205. doi: 10.1186/s12885-023-11434-9.
6
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling.建立用于高级别子宫内膜癌的全面患者来源异种移植模型面板:分子亚型、基因改变和治疗靶点分析。
Neoplasia. 2025 Jun;64:101158. doi: 10.1016/j.neo.2025.101158. Epub 2025 Apr 7.
7
Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis.患者来源的类器官反映子宫内膜肿瘤的基因特征并预测患者预后。
Commun Med (Lond). 2021 Jul 30;1:20. doi: 10.1038/s43856-021-00019-x. eCollection 2021.
8
Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy.用于监测肿瘤进展和靶向治疗反应的临床前子宫内膜癌模型成像
Cancers (Basel). 2019 Nov 27;11(12):1885. doi: 10.3390/cancers11121885.
9
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.患者来源异种移植模型捕获子宫内膜癌中的基因组异质性。
Genome Med. 2022 Jan 10;14(1):3. doi: 10.1186/s13073-021-00990-z.
10
Feasibility and utility of MRI and dynamic F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer.基于器官型子宫内膜癌患者来源的小鼠模型的 MRI 和动态 F-FDG-PET 的可行性和实用性。
J Transl Med. 2021 Sep 26;19(1):406. doi: 10.1186/s12967-021-03086-9.

本文引用的文献

1
Development of an RNA virus-based episomal vector with artificial aptazyme for gene silencing.基于 RNA 病毒的人工适体酶切元件型载体的构建及其用于基因沉默。
Appl Microbiol Biotechnol. 2024 Oct 18;108(1):491. doi: 10.1007/s00253-024-13327-8.
2
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.子宫内膜癌的分子分类及其对治疗选择的影响。
Int J Mol Sci. 2024 May 28;25(11):5893. doi: 10.3390/ijms25115893.
3
Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer.从一例晚期子宫内膜癌病例中建立和表征多个患者来源的类器官。
Hum Cell. 2024 May;37(3):840-853. doi: 10.1007/s13577-024-01048-z. Epub 2024 Mar 28.
4
Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment.子宫内膜癌预防、早期诊断与治疗的最新进展
Cancers (Basel). 2024 Mar 1;16(5):1028. doi: 10.3390/cancers16051028.
5
Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.分子分类在指导年轻子宫内膜癌患者保留生育力管理中的潜力。
Gynecol Oncol. 2024 Jun;185:121-127. doi: 10.1016/j.ygyno.2024.02.020. Epub 2024 Feb 24.
6
Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation.子宫内膜癌的分子亚型:指导生育力保存的有前途策略。
Gynecol Oncol. 2023 Dec;179:180-187. doi: 10.1016/j.ygyno.2023.11.006. Epub 2023 Nov 21.
7
A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation.一项基于患者来源的类器官的研究通过降低异常 FOXM1 表达和 β-连环蛋白核积累,确定了一种针对 SNORD14E 的反义寡核苷酸(ASO)作为子宫内膜癌的治疗靶点。
J Exp Clin Cancer Res. 2023 Sep 5;42(1):230. doi: 10.1186/s13046-023-02801-2.
8
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.分子分类预测早期子宫内膜样型子宫内膜癌随机 PORTEC-1 和 PORTEC-2 试验中放疗的反应。
J Clin Oncol. 2023 Sep 20;41(27):4369-4380. doi: 10.1200/JCO.23.00062. Epub 2023 Jul 24.
9
A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities.一种新型的小鼠子宫内膜癌模型揭示了遗传驱动因素的功能作用并探讨了它们的易感性。
Adv Sci (Weinh). 2023 Aug;10(24):e2300383. doi: 10.1002/advs.202300383. Epub 2023 Jun 20.
10
Establishment of a human microbiome- and immune system-reconstituted dual-humanized mouse model.建立人类微生物组和免疫系统重建的双重人源化小鼠模型。
Exp Anim. 2023 Aug 7;72(3):402-412. doi: 10.1538/expanim.23-0025. Epub 2023 Apr 4.

子宫内膜癌的临床前研究模型:动物模型的建立与选择

Preclinical research models for endometrial cancer: development and selection of animal models.

作者信息

Xue Yang, Shi Wei, Lun Bing, Kan Meilin, Jia Mengling, Wu Yuelin, Yang Li

机构信息

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zhengzhou Key Laboratory of Endometrial Disease Prevention and Treatment, Zhengzhou, China.

出版信息

Front Oncol. 2025 Feb 5;15:1512616. doi: 10.3389/fonc.2025.1512616. eCollection 2025.

DOI:10.3389/fonc.2025.1512616
PMID:39975595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11835666/
Abstract

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with rising incidence in recent years. Experimental animal models are crucial for studying the pathogenesis, advancing diagnostic methods, and developing new treatments. We review five main EC animal models. The use of spontaneous and chemically-induced models has decreased, with transgenic mouse and xenograft models becoming the most widely used. These models better simulate tumor molecular mechanisms and treatments, with the organoid-based patient-derived xenograft model (O-PDX) showing great promise in drug screening and personalized therapy. The application of humanized models remains limited due to technical challenges and high costs. In this review, we highlight the strengths and limitations of each model to guide researchers in their selection.

摘要

子宫内膜癌(EC)是发达国家最常见的妇科恶性肿瘤,近年来发病率呈上升趋势。实验动物模型对于研究发病机制、推进诊断方法和开发新疗法至关重要。我们综述了五种主要的子宫内膜癌动物模型。自发模型和化学诱导模型的使用有所减少,转基因小鼠模型和异种移植模型成为使用最广泛的模型。这些模型能更好地模拟肿瘤分子机制和治疗方法,基于类器官的患者来源异种移植模型(O-PDX)在药物筛选和个性化治疗方面显示出巨大潜力。由于技术挑战和成本高昂,人源化模型的应用仍然有限。在本综述中,我们强调了每种模型的优缺点,以指导研究人员进行选择。